Pharmacokinetics (PK)

Pharmacokinetics (PK) describes what the body does to a drug, representing the quantitative study of drug movement through absorption, distribution, metabolism, and excretion pathways. This fundamental discipline informs every stage of pharmaceutical development from early discovery through post-market surveillance, ensuring therapeutic agents achieve desired concentrations at target sites.

PK principles drive critical decisions in drug development programmes. Scientists use compartmental modelling and population PK approaches to predict drug behaviour across patient demographics, disease states, and concomitant therapies. These analyses reveal whether a compound requires once-daily dosing or continuous infusion, whether food affects absorption, and how renal or hepatic impairment influences drug clearance. The biopharmaceutical industry has witnessed revolutionary advances in PK methodologies, particularly with the rise of biologics and biosimilars. Large-molecule therapeutics face additional PK considerations including target-mediated drug disposition and anti-drug antibody formation. Modern PK studies employ sophisticated bioanalytical platforms such as liquid chromatography-mass spectrometry and immunoassays to track drug concentrations with precision across diverse patient populations.